Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies in 12,809 hypertensive patients

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2757-2764

  Costanzo, Pierluigi ^a   Savarese, Gianluigi ^b   Rosano, Giuseppe ^c   Musella, Francesca ^b   Casaretti, Laura ^b   Vassallo, Enrico ^b   Paolillo, Stefania ^b   Marsico, Fabio ^b   Rengo, Giuseppe ^b   Leosco, Dario ^b   Perrone Filardi, Pasquale ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Cardiovascular risk; Left ventricular hypertrophy; Meta analysis

Indexed keywords

AMLODIPINE; ATENOLOL; DOXAZOSIN; ENALAPRIL; LISINOPRIL; LOSARTAN; NISOLDIPINE; NITRENDIPINE; PLACEBO; RAMIPRIL; VALSARTAN;

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DEATH; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE;

CARDIOVASCULAR RISK; LEFT VENTRICULAR HYPERTROPHY; META-ANALYSIS;

AGED; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS;

EID: 84883803799     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.084     Document Type: Article

References (35)

1. G. Mancia, G. De Backer, and A. Dominiczak 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
2. I. Graham, D. Atar, and K. Borch-Johnsen European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 2007 E1 E40
3. R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study N Engl J Med 322 1990 1561 1566
4. M.J. Koren, R.B. Devereux, P.N. Casale, D.D. Savage, and J.H. Laragh Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension Ann Intern Med 114 1991 345 352
5. C. Cipriano, P. Gosse, and L. Bemurat Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients Am J Hypertens 14 2001 524 529
6. P. Verdecchia, F. Angeli, and C. Borgioni Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis Am J Hypertens 16 2003 895 899
7. S.D. Pierdomenico, and F. Cuccurullo Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis Am J Hypertens 23 2010 876 881
8. G. Schillaci, P. Verdecchia, C. Porcellati, O. Cuccurullo, C. Cosco, and F. Perticone Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension Hypertension 35 2000 580 586
9. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
10. G. Savarese, S. Paolillo, and P. Costanzo Do changes in 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials J Am Coll Cardiol 60 13 2012 Sep 25 1192 1201
11. P. Costanzo, P. Perrone-Filardi, and M. Petretta Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients J Hypertens 27 2009 1136 1151
12. G. Boner, M.E. Cooper, and K. McCarroll Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study Diabetologia 48 2005 1980 1987
13. B. Dahlöf, R.B. Devereux, and S.E. Kjeldsen Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995 1003
14. B. Dahlof, A. Zanchetti, and J. Diez Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy J Hypertens 20 2002 1855 1864
15. T.A. Gerritsen, A.A. Bak, R.P. Stolk, J.J. Jonker, and D.E. Grobbee Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension J Hypertens 16 1998 689 696
16. E.P. Havranek, A. Esler, R.O. Estacio, P.S. Mehler, and R.W. Schrier Appropriate blood pressure control in diabetes trial. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the appropriate blood pressure control in diabetes (ABCD) trial Am Heart J 145 2003 993 998
17. W.F. Heesen, F.W. Beltman, and A.J. Smit Reversal of pathophysiologic changes with long-term lisinopril treatment in isolated systolic hypertension J Cardiovasc Pharmacol 37 2001 512 521
18. C. Hotu, W. Bagg, and J. Collins A community-based model of care improves blood pressure control and delays progression of proteinuria, left ventricular hypertrophy and diastolic dysfunction in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a randomized controlled trial Nephrol Dial Transplant 25 2010 3260 3266
19. B.V. Howard, M.J. Roman, and R.B. Devereux Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial JAMA 299 2008 1678 1689
20. M. Lièvre, P. Guéret, and C. Gayet Ramipril induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR study group Hypertension 25 1995 92 97
21. Y. Matsui, K. Eguchi, and S. Shibasaki Effect of doxazosin on the left ventricular structure and function in morning hypertensive patients: the Japan morning surge 1 study J Hypertens 26 2008 1463 1471
22. S.D. Solomon, R. Janardhanan, and A. Verma Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial Lancet 369 2007 2079 2087
23. H. Takano, H. Hasegawa, and H. Narumi Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART J Hum Hypertens 26 11 2012 656 663
24. W.F. Terpstra, J.F. May, and A.J. Smit Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial J Hypertens 19 2001 303 309
25. K. Yamamoto, H. Ozaki, and K. Takayasu The effect of losartan and amlodipine on left ventricular diastolic function and atherosclerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study Hypertens Res 34 2011 325 330
26. S. Sharp, and J. Sterne Meta-analysis Stata technical bulletin reprints 7 1998 100 108
27. A. Whitehead Meta-analysis of controlled clinical trials 2002 John Wiley & Sons Chichester, England 4
28. H.T. Davies, I.K. Crombie, and M. Tavakoli When can odds ratios mislead? BMJ 316 1998 989 991
29. M. Woodward Epidemiology, study design and data analysis 1999 Chapman and Hall London
30. S.G. Thompson, and S.J. Sharp Explaining heterogeneity in meta-analysis: a comparison of methods Stat Med 18 1999 2693 2708
31. J.L. Peters, A.J. Sutton, D.R. Jones, K.R. Abrams, and L. Rushton Comparison of two methods to detect publication bias in meta-analysis JAMA 295 2006 676 680
32. T. Pellegrino, G. Storto, and P. Perrone Filardi Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease J Nucl Med 46 2005 1997 2002
33. P. Perrone Filardi, A. Cuocolo, and G. Brevetti Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease Am J Cardiol 9 2005 1337 1341
34. P.G. Camici, and F. Crea Coronary microvascular dysfunction N Engl J Med 356 2007 830 840
35. P. Verdecchia, C. Porcellati, and G. Schillaci Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension Hypertension 24 1994 793 801